D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORTX
3751
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $200K | ﹤0.01% |
+1,458
| New | +$177K |
|
|
ACGN
3752
DELISTED
Aceragen Inc
ACGN
| $200K | ﹤0.01% |
6,479
-308
| -5% | -$11.5K |
|
3753
TFS Financial
TFSL
$5.1B
| $199K | ﹤0.01% |
10,126
-6,677
| -40% | -$129K |
|
3754
American Coastal Insurance
ACIC
$498M
| $198K | ﹤0.01% |
+15,678
| New | +$199K |
|
|
CMO
3755
DELISTED
Capstead Mortgage Corp.
CMO
| $198K | ﹤0.01% |
+25,029
| New | +$193K |
|
|
DS
3756
DELISTED
Drive Shack Inc.
DS
| $196K | ﹤0.01% |
53,490
+6,721
| +14% | +$26.7K |
|
3757
Cytosorbents Corp
CTSO
$22.6M
| $195K | ﹤0.01% |
+50,767
| New | +$221K |
|
|
SFE
3758
DELISTED
Safeguard Scientifics, Inc.
SFE
| $195K | ﹤0.01% |
17,776
-25,859
| -59% | -$296K |
|
3759
HBT Financial
HBT
$1.21B
| $194K | ﹤0.01% |
+10,237
| New | +$175K |
|
3760
DigitalBridge
DBRG
$2.94B
| $193K | ﹤0.01% |
10,163
-1,967
| -16% | -$40.5K |
|
|
CNSL
3761
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $193K | ﹤0.01% |
49,690
+27,486
| +124% | +$106K |
|
3762
PUT
Under Armour Class C
UA
$2.92B
| $192K | ﹤0.01% |
10,000
| – | – |
|
3763
Barnes & Noble Education
BNED
$412M
| $191K | ﹤0.01% |
448
-149
| -25% | -$61.3K |
|
3764
Newmark Group
NMRK
$2.73B
| $190K | ﹤0.01% |
14,145
-4,280
| -23% | -$49.9K |
|
3765
Gladstone Investment Corp
GAIN
$635M
| $189K | ﹤0.01% |
+14,282
| New | +$193K |
|
|
ITI
3766
DELISTED
Iteris, Inc.
ITI
| $187K | ﹤0.01% |
37,555
-14,759
| -28% | -$75.1K |
|
3767
Rafael Holdings
RFL
$111M
| $186K | ﹤0.01% |
10,599
-4,222
| -28% | -$76.9K |
|
3768
Anavex Life Sciences
AVXL
$222M
| $185K | ﹤0.01% |
+71,550
| New | +$188K |
|
3769
Hecla Mining
HL
$10.2B
| $185K | ﹤0.01% |
54,500
+32,956
| +153% | +$80.8K |
|
3770
Intellia Therapeutics
NTLA
$1.5B
| $185K | ﹤0.01% |
+12,625
| New | +$176K |
|
3771
Duluth Holdings
DLTH
$160M
| $184K | ﹤0.01% |
+17,502
| New | +$163K |
|
3772
Wave Life Sciences
WVE
$1.12B
| $181K | ﹤0.01% |
22,548
+3,858
| +21% | +$94.6K |
|
3773
Fidus Investment
FDUS
$737M
| $180K | ﹤0.01% |
+12,112
| New | +$182K |
|
|
FLG
3774
CALL
Flagstar Bank National Association
FLG
$5.77B
| $180K | ﹤0.01% |
5,000
| – | – |
|
|
AXAS
3775
DELISTED
Abraxas Petroleum Corp
AXAS
| $180K | ﹤0.01% |
25,579
-15,677
| -38% | -$101K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.